Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Whats the consensus on the two presentations this month?

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jun 02, 2021 2:51pm

155 Views

Post# 33312155

RE:Whats the consensus on the two presentations this month?

You are able to edit your abstract until the submission deadline. After the submission deadline, no changes are allowed. Any corrections, withdrawals and/or changes will not be accepted after this date. Please note: the submission fee is final and non-refundable regardless of abstract edits or withdrawal.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing